
Retina
Latest News


EURETINA 2024: Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use

EURETINA 2024: CRISPR-Cas mediated base editing approaches for CRB1 related retinal dystrophy
Video Series

CME Content

Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab

Carl Awh, MD, FASRS, spoke the value of the international community of retina clinicians connecting at global meetings

Carl Awh, MD, FASRS, spoke about the presence of members of the American Society of Retina Specialists (ASRS) attending the EURETINA meeting and the value of the international community of retina clinicians connecting at meetings around the globe.

Additionally, FDA grants Fast Track Designation to brepocitinib for non-infectious uveitis.

The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of the EMA's initial response

Stefano Mercuri, MD, speaks about his team's August Deutman award-winning research on retinitis pigmentosa and Rho gene mutations



Clare Bailey, MD, shared data from the multi-country study on faricimab for patients with DME and nAMD

Prof Bodaghi praises the ingenuity at this year's EURETINA Innovation Spotlight (EIS)

Challenging surgical videos from the Vit-Buckle Society symposia and data on the impact of home OCT in management of nAMD


Editorial advisory board member Alexandra Miere, MD, PhD, says oculomics is the next big thing in eye care

Additional previous surgeries and the duration of the SO tamponade had little or no impact

Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial

New research and EURETINA highlights from the director of the "underdog" eye clinic

How retinal imaging can provide clinicians a deeper understanding of myopia

Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"

The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and Emerging Therapies.

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk

We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA

Efferocytosis’ role in retinopathy is largely unknown despite knowledge of the process in other diseases.

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies

Why having a set process for diagnostic imaging is crucial to patient outcomes
















